Clinical trial
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
NCT01841242 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 23, 2013
- Completion date
- January 31, 2021
- Enrollment
- 2,272 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia, heart failure